1. EURISOL Site Investigation Panel

2. Nuclear Physics is going through an exciting exploration period Exploration needs new facilities The EURISOL project is making good progress High powered ISOL systems are technically challenging

3. Single National Facility R and D Financial Cost For site  Detailed engineering design

4. International Facility R and D Financial Cost Detailed engineering design Site Site type A B C D Science/ Timescale International Collaboration

5. To initiate the process of identifying the EURISOL site the BOM is appointing a Panel to investigate the consequences of different types of sites and how they ( in general terms) potentially concern:  Science/ Timescale  Costs  Trans European Collaboration Site Types: National Nuclear Physics Laboratory National Physics Laboratory International Laboratory  CERN Green Field Site

6. The panel is NOT charged with the final decision for site selection. Concerned with issues that will have to be investigated and evaluated for a final site selection decision.

7. Europe has excellent history of collaboration CERN - European Organization for Nuclear Research EFDA - European Fusion Development Agreement EMBL - European Molecular Biology Laboratory EFDA - European Fusion Development Agreement EMBL - European Molecular Biology Laboratory ESA - European Space Agency ESO - European Organisation for Astronomical Research in the Southern Hemisphere ESRF - European Synchrotron Radiation Facility ILL - Institut Laue LangevinSA - European Space Agency ESO - European Organisation for Astronomical Research in the Southern Hemisphere ESRF - European Synchrotron Radiation Facility ILL - Institut Laue Langevin ~50 19 17 12 20 13

8. Panel Details  5 Panel members  Look at history of funding for other European Facilities Funding/ site determination  Define factors that should be evaluated for the 4 generic site models in a final site determination (Factors would include timescale, overall general costs, multinational buy-in  Scientific/ Funding agencies)  Visit a selection of current laboratories  Recommend a procedure to move the site determination forward  Report ready end 2008 Welcome comments from the community on any aspect of the panels activities  ashotter@triumf.ca

9. Site Selection can be a sensitive issueRIA Internationalization of a facility can be challenging FAIR ILC GDE FALC Much can be learned from other initiatives ICFA (IUPAP)

10. ashotter@triumf.ca

12. These are some of the factors that have to be investigated for different types of sites 1)National nuclear physics laboratory,. 2)Large international subatomic physics laboratory 3)National laboratory with a general portfolio. 4) Green field site. The task for the SIP would be to investigate the factors a) to h) in relation to site types 1) - 4).

13. a)Land issues: availability, leasing, local basic infrastructure, ownership, acceptability to local population. b)Licensing and safety issues: European legislation, host country legislation, local population issues. c)General site infrastructure: workshops, design experience, administrative structures, local accommodation. d)Local large scale construction history: history of successful construction of a large scale projects. e) Experience of high-powered targets ISOL systems i.e. local experience of issues of the operating with high powered targets systems. f) Local nuclear physics infrastructure: local facility engineering, technical and safety experience. g) Acceptance of a local host country for a European site. h) Political acceptance of the majority of countries for a particular site solution. First task of the panel is to identify in detail the factors that need consideration in a final selection process

14. Europe has a great history of scientific endeavour, underpinning our quality of life and fundamental to our European identity. Science is a team effort and to progress, it often needs special and large facilities, some of which require resources beyond the means of any single country. Since the early 1950s, a number of intergovernmental research organisations have been established to fulfil the needs of Europe's scientists. They bring together expertise and funding from across the continent and have been remarkably successful in developing and operating some of the largest and most advanced research infrastructures in the world. Their excellence in their respective fields enables European scientists to perform world-leading research. EIROforum is a partnership of Europe's seven largest intergovernmental research organisations. In EIROforum, these organisations pursue joint initiatives, combine resources, and share best practices. The seven EIROforum members are: CERN - European Organization for Nuclear Research EFDA - European Fusion Development Agreement EMBL - European Molecular Biology Laboratory ESA - European Space Agency ESO - European Organisation for Astronomical Research in the Southern Hemisphere ESRF - European Synchrotron Radiation Facility ILL - Institut Laue Langevin CERN - European Organization for Nuclear Research EFDA - European Fusion Development Agreement EMBL - European Molecular Biology Laboratory ESA - European Space Agency ESO - European Organisation for Astronomical Research in the Southern Hemisphere ESRF - European Synchrotron Radiation Facility ILL - Institut Laue Langevin EIROforum

15. In 1988, twelve European countries joined forces to create the synchrotron in Grenoble. Since then, six more countries have joined the group. Together they create the indispensable synergy needed to carry out advanced scientific research. Members' share in contribution to the annual budget: 27.5% France 25.5% Germany 15% Italy 14% United Kingdom 4% Spain 4% Switzerland 6% Benesync (Belgium, The Netherlands) 4% Nordsync (Denmark, Finland, Norway, Sweden) Additional contributions (percentages refer to Members' total contribution): 1% Portugal 1% Israel 1% Austria 1% Poland 0.47% Czech Republic 0.2% Hungary The 2007 budget for operating the ESRF is 80 million Euros. Staff: About 600 people work at the ESRF. Visiting researchers: About 6000 researchers come each year at the ESRF to carry out experiments. ESRF

16. ILL was founded on 19 January 1967 with the signing of an agreement between the governments of the French Republic and the Federal Republic of Germany. The friendship and influence of Louis Néel and Heinz Maier-Leibnitz brought this project to fruition in Grenoble. The ILL had the innovative status of a service institute, offering the scientific community the world's leading facilities in neutron science and technology- a large cold neutron source and ten neutron guides, each capable of serving three or four instruments with a very high intensity neutron flux... The construction of the Institute and its high-flux reactor in Grenoble, representing an overall investment of 335 million francs, was jointly undertaken by France and Germany. In August 1971, the reactor went critical and reached full power (57 MW) in December of that year. Experiments began in 1972. In January 1973, the United Kingdom decided to join ILL and officially became the institute’s third Associate member country with the signing of the agreement of 19 July 1974. Ten countries have signed “Scientific Membership” agreements with ILL: Spain (1987), Switzerland (1988), Austria (1990), Russia (1996), Italy (1997), the Czech Republic (1999), Sweden and Hungary (2005), Belgium and Poland (2006). Under the terms of these agreements, scientists from these countries are given access to ILL’s instruments for a specified percentage of overall beam time under the same conditions as scientists from the three Associate member countries. The ILL's beams and instruments are provided free of charge to researchers whose experimental proposals have been accepted. Applications for beam time are submitted electronically twice a year; they are peer-reviewed by external experts. Every year 2000 scientists visit the ILL from over 1000 laboratories in 45 different countries across the world to perform as many as 750 experiments each year. The ILL 's contributions to high-impact scientific journals is almost double that of its nearest competitors and testifies to the success of our facility. The Institute has been an exceptional centre of excellence, a fine example of successful co-operation in Europe and a prototype of the European Research Area. ILL